Normal Coagulation Profile - No Action Required
These values (PT 10.6 seconds, INR 1.02) are completely normal and require no intervention, correction, or further workup in a patient not taking anticoagulants.
Interpretation
Your patient's results fall well within the normal reference range:
- PT of 10.6 seconds: Normal (typical range 11-13.5 seconds, though this varies slightly by laboratory)
- INR of 1.02: Normal (reference range 0.8-1.2 for patients not on anticoagulation)
These values indicate normal function of the extrinsic coagulation pathway, including adequate levels of factors II, V, VII, X, and fibrinogen.
Critical Context About INR Use
The INR was specifically designed and validated ONLY for monitoring patients on vitamin K antagonists (warfarin). 1 The standardization relies on plasma samples from patients on stable warfarin therapy, and the INR scale is formally invalid when used outside this context 2, 3.
Despite widespread misuse, there is no high-quality evidence supporting INR targets or treatment for values below 2.0 in patients not receiving vitamin K antagonist therapy 1. The INR lacks both face validity and clinical evidence for uses other than warfarin monitoring 1.
Common Pitfalls to Avoid
Do NOT:
- Order plasma transfusion for mildly elevated INR values (1.0-2.0 range) in asymptomatic patients not on warfarin - this provides no clinical benefit and causes harm 1
- Use INR to predict procedural bleeding risk in patients not on warfarin
- Apply therapeutic INR ranges (2.0-3.0) to patients without anticoagulation 4, 2
Clinical Scenarios Where These Values Matter:
If considering anticoagulation initiation (e.g., atrial fibrillation, mechanical valve, VTE):
- These normal baseline values confirm no pre-existing coagulopathy
- For warfarin therapy: Target INR 2.0-3.0 for most indications (atrial fibrillation, VTE) 5, 4
- For mechanical heart valves: Target INR 2.5-3.5 4
- Monitor INR weekly during warfarin initiation, then monthly when stable 5
If patient has liver disease:
- The standard INR is not valid for assessing hepatic synthetic function 2
- A modified INR-liver scale exists but is not widely implemented
- Do not use these values to guide plasma transfusion decisions
Bottom Line
With a PT of 10.6 seconds and INR of 1.02 in a patient not on anticoagulants, document these as normal baseline coagulation parameters and proceed with clinical care as planned. No correction, reversal, or additional coagulation testing is indicated based on these results alone.